A Phase 2, Open-Label, Multicenter Study of Single-Agent

Project: Research project

Project Details

Description

A Phase 2, Open-Label, Multicenter Study of Single-Agent Enzastaurin in Patients with Relapsed Cutaneous T-Cell Lymphoma
StatusFinished
Effective start/end date10/14/0812/31/11

Funding

  • Eli Lilly and Company

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.